Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A novel chimeric promoter that is highly responsive to hypoxia and metals

Abstract

To develop a potent hypoxia-inducible promoter, we evaluated the usefulness of chimeric combinations of the (Egr-1)-binding site (EBS) from the Egr-1 gene, the metal-response element (MRE) from the metallothionein gene, and the hypoxia-response element (HRE) from the phosphoglycerate kinase 1 gene. In transient transfection assays, combining three copies of HRE (3 × HRE) with either EBS or MRE significantly increased hypoxia responsiveness. When a three-enhancer combination was tested, the EBS–MRE-3 × HRE (E–M–H) gave a hypoxia induction ratio of 69. The expression induced from E–M–H-pGL3 was 2.4-fold higher than that induced from H-pGL3 and even surpassed the expression from a human cytomegalovirus promoter-driven vector. The high inducibility of E–M–H was confirmed by validation studies in different cells and by expressing other cDNAs. Gel shift assays together with functional overexpression studies suggested that increased levels of hypoxia-inducible factor 1α, metal transcription factor-1 and Egr-1 may be associated with the high inducibility of the E–M–H chimeric promoter. E–M–H was also induced by hypoxia mimetics such as Co2+ and deferoxamine (DFX) and by hydrogen peroxide. Gene expression from the E–M–H was reversible as shown by the reduced expression of the transgene upon removal of inducers such as hypoxia and DFX. In vivo evaluation of the E–M–H in ischemic muscle revealed that erythropoietin secretion and luciferase and LacZ expression were significantly higher in the E–M–H group than in a control or H group. With its high induction capacity and versatile means of modulation, this novel chimeric promoter should find wide application in the treatment of ischemic diseases and cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Zixuan Zhao, Xinyi Chen, … Hanry Yu

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Guillemin K, Krasnow MA . The hypoxic response: huffing and HIFing. Cell 1997; 89: 9–12.

    Article  CAS  Google Scholar 

  2. Boast K, Binley K, Iqball S, Price T, Spearman H, Kingsman S et al. Characterization of physiologically regulated vectors for the treatment of ischemic disease. Hum Gene Ther 1999; 10: 2197–2208.

    Article  CAS  Google Scholar 

  3. Greco O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD . Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Therapy 2002; 9: 1403–1411.

    Article  CAS  Google Scholar 

  4. Su H, Arakawa-Hoyt J, Kan YW . Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 2002; 99: 9480–9485.

    Article  CAS  Google Scholar 

  5. Shibata T, Giaccia AJ, Brown JM . Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy. Neoplasia 2002; 4: 40–48.

    Article  CAS  Google Scholar 

  6. Binley K, Askham Z, Martin L, Spearman H, Day D, Kingsman S et al. Hypoxia-mediated tumour targeting. Gene Therapy 2003; 10: 540–549.

    Article  CAS  Google Scholar 

  7. Shibata T, Giaccia AJ, Brown JM . Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Therapy 2000; 7: 493–498.

    Article  CAS  Google Scholar 

  8. Murphy BJ, Andrews GK, Bittel D, Discher DJ, McCue J, Green CJ et al. Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res 1999; 59: 1315–1322.

    CAS  Google Scholar 

  9. Green CJ, Lichtlen P, Huynh NT, Yanovsky M, Laderoute KR, Schaffner W et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 2001; 61: 2696–2703.

    CAS  Google Scholar 

  10. Yan SF, Lu J, Zou YS, Soh-Won J, Cohen DM, Buttrick PM et al. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 1999; 274: 15030–15040.

    Article  CAS  Google Scholar 

  11. Saydam N, Georgiev O, Nakano MY, Greber UF, Schaffner W . Nucleo-cytoplasmic trafficking of metal-regulatory transcription factor 1 is regulated by diverse stress signals. J Biol Chem 2001; 276: 25487–25495.

    Article  CAS  Google Scholar 

  12. Lee SL, Tourtellotte LC, Wesselschmidt RL, Milbrandt J . Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J Biol Chem 1995; 270: 9971–9977.

    Article  CAS  Google Scholar 

  13. Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355–1361.

    Article  CAS  Google Scholar 

  14. Okada M, Wang CY, Hwang DW, Sakaguchi T, Olson KE, Yoshikawa Y et al. Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ Res 2002; 91: 135–142.

    Article  CAS  Google Scholar 

  15. Ohtani K, Egashira K, Usui M, Ishibashi M, Hiasa KI, Zhao Q et al. Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits. Gene Therapy 2004; 11: 126–132.

    Article  CAS  Google Scholar 

  16. Lee YS, Jang HS, Kim JM, Lee JS, Lee JY, Kim KL et al. Adenoviral-mediated delivery of early growth response factor-1 gene increases tissue perfusion in a murine model of hindlimb ischemia. Mol Ther 2005; 12: 328–336.

    Article  CAS  Google Scholar 

  17. Gong P, Hu B, Stewart D, Ellerbe M, Figueroa YG, Blank V et al. Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: regulation by Nrf2 and MafG transcription factors. J Biol Chem 2001; 276: 27018–27025.

    Article  CAS  Google Scholar 

  18. Zhu H, Bunn HF . Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respir Physiol 1999; 115: 239–247.

    Article  CAS  Google Scholar 

  19. Gill G, Ptashne M . Negative effect of the transcriptional activator GAL4. Nature 1988; 334: 721–724.

    Article  CAS  Google Scholar 

  20. Flanagan PM, Kelleher III RJ, Sayre MH, Tschochner H, Kornberg RD . A mediator required for activation of RNA polymerase II transcription in vitro. Nature 1991; 350: 436–438.

    Article  CAS  Google Scholar 

  21. Cahill MA, Ernst WH, Janknecht R, Nordheim A . Regulatory squelching. FEBS Lett 1994; 344: 105–108.

    Article  CAS  Google Scholar 

  22. Jang HS, Kim HJ, Kim JM, Lee YS, Kim KL, Kim JA et al. A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle. Mol Ther 2004; 9: 464–474.

    Article  CAS  Google Scholar 

  23. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114–1123.

    Article  CAS  Google Scholar 

  24. Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther 1999; 10: 2953–2960.

    Article  CAS  Google Scholar 

  25. Perrin LA, June JE, Rosebury W, Robertson A, Kovesdi I, Bruder JT et al. Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121). Gene Therapy 2004; 11: 512–521.

    Article  CAS  Google Scholar 

  26. Marples B, Greco O, Joiner MC, Scott SD . Molecular approaches to chemo-radiotherapy. Eur J Cancer 2002; 38: 231–239.

    Article  CAS  Google Scholar 

  27. Greco O, Marples B, Joiner MC, Scott SD . How to overcome (and exploit) tumor hypoxia for targeted gene therapy. J Cell Physiol 2003; 197: 312–325.

    Article  CAS  Google Scholar 

  28. Small S, Arnosti DN, Levine M . Spacing ensures autonomous expression of different stripe enhancers in the even-skipped promoter. Development 1993; 119: 762–772.

    CAS  PubMed  Google Scholar 

  29. Nikolajczyk BS, Cortes M, Feinman R, Sen R . Combinatorial determinants of tissue-specific transcription in B cells and macrophages. Mol Cell Biol 1997; 17: 3527–3535.

    Article  CAS  Google Scholar 

  30. Vaupel P, Schlenger K, Knoop C, Hockel M . Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 1991; 51: 3316–3322.

    CAS  Google Scholar 

  31. Brown JM, Wilson WR . Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004; 4: 437–447.

    Article  CAS  Google Scholar 

  32. Binley K, Iqball S, Kingsman A, Kingsman S, Naylor S . An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Therapy 1999; 6: 1721–1727.

    Article  CAS  Google Scholar 

  33. Harris AL . Hypoxia – a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38–47.

    Article  CAS  Google Scholar 

  34. Zhang B, Georgiev O, Hagmann M, Gunes C, Cramer M, Faller P et al. Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by metallothionein. Mol Cell Biol 2003; 23: 8471–8485.

    Article  CAS  Google Scholar 

  35. Lim CP, Jain N, Cao X . Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 1998; 16: 2915–2926.

    Article  CAS  Google Scholar 

  36. Chun YS, Lee KH, Choi E, Bae SY, Yeo EJ, Huang LE et al. Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion. Cancer Res 2003; 63: 8700–8707.

    CAS  PubMed  Google Scholar 

  37. Stuart GW, Searle PF, Chen HY, Brinster RL, Palmiter RD . A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous gene. Proc Natl Acad Sci USA 1984; 81: 7318–7322.

    Article  CAS  Google Scholar 

  38. Stuart GW, Searle PF, Palmiter RD . Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences. Nature 1985; 317: 828–831.

    Article  CAS  Google Scholar 

  39. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ et al. Targeting gene expression to hypoxic tumor cells. Nat Med 1997; 3: 515–520.

    Article  CAS  Google Scholar 

  40. Herweijer H, Wolff JA . Progress and prospects: naked DNA gene transfer and therapy. Gene Therapy 2003; 10: 453–458.

    Article  CAS  Google Scholar 

  41. Ruan H, Su H, Hu L, Lamborn KR, Kan YW, Deen DF . A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 2001; 3: 255–263.

    Article  CAS  Google Scholar 

  42. Dalton TP, Bittel D, Andrews GK . Reversible activation of mouse metal response element-binding transcription factor 1 DNA binding involves zinc interaction with the zinc finger domain. Mol Cell Biol 1997; 17: 2781–2789.

    Article  CAS  Google Scholar 

  43. Khachigian LM, Williams AJ, Collins T . Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem 1995; 270: 27679–27686.

    Article  CAS  Google Scholar 

  44. Dalton TP, Li Q, Bittel D, Liang L, Andrews GK . Oxidative stress activates metal-responsive transcription factor-1 binding activity. Occupancy in vivo of metal response elements in the metallothionein-I gene promoter. J Biol Chem 1996; 271: 26233–26241.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Research Laboratory Grant from the Korea Institute of Science and Technology Evaluation and Planning (M1-0412-00-0048) and the grants from the Korean Ministry of Health and Welfare (01-PJ1-PG1-01CH06-0003) and the Korea Science and Engineering Foundation (SRC, Molecular Therapy Research Center) to DK Kim.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J Byun or D-K Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JY., Lee, YS., Kim, JM. et al. A novel chimeric promoter that is highly responsive to hypoxia and metals. Gene Ther 13, 857–868 (2006). https://doi.org/10.1038/sj.gt.3302728

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302728

Keywords

This article is cited by

Search

Quick links